Table 3. Estimated Clearance, Rate Constants (ke, k12, k21), Terminal Half-life (T1/2λz) Initial Volume of Distribution (V1), and Volume of Distribution at Steady State (VDss) in Patients Receiving Bambuterol or Placebo
Medians and ranges are given.
* Statistically significant difference (P < 0.05).